1192: COVID SEPSIS GENE EXPRESSION SUBPHENOTYPES MANIFEST DIFFERENTIAL PLASMA PROTEIN SIGNATURES
H.M. Giannini(Lung Institute), Nuala J. Meyer(Translational Therapeutics (United States)), L. H. Turner(California University of Pennsylvania), John Reilly(University of Pennsylvania), R.S. Agyekum(Translational Therapeutics (United States)), Todd A. Miano(University of Pennsylvania), Lukas Ronner(Hospital of the University of Pennsylvania), Oliver Liesenfeld(Franklin University), Tiffanie K. Jones(University of Pennsylvania), Timothy E. Sweeney, Christopher Cosgriff(Massachusetts General Hospital), Lisa R. Sun(Johns Hopkins University), M.G.S. Shashaty(University of Pennsylvania), Thomas Dunn(Translational Therapeutics (United States)), C.A.G. Ittner(University of Pennsylvania)
Cited by 0
Related Papers
Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications
|Science|2020|1.7k
ESICM guidelines on acute respiratory distress syndrome: definition, phenotyping and respiratory support strategies
|Intensive Care Medicine|2023|855
Comprehensive mapping of immune perturbations associated with severe COVID-19
|Science Immunology|2020|806
Inflammasome-regulated Cytokines Are Critical Mediators of Acute Lung Injury
|American Journal of Respiratory and Critical Care Medicine|2012|566
CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer
|Nature Medicine|2021|521